Elevated platelet lymphocyte ratio is a poor prognostic factor in advanced epithelial ovarian cancer
Authors:
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 50 (6) , 101849
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancerJournal of Gynecologic Oncology, 2012
- PlateletsArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Immunity, Inflammation, and CancerCell, 2010
- Role of Systemic Inflammatory Response in Predicting Survival in Patients with Primary Operable CancerFuture Oncology, 2009
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instabilityCarcinogenesis, 2009
- Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literatureJournal of Ovarian Research, 2009
- Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancerCritical Reviews in Oncology/Hematology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Cancer-related inflammationNature, 2008